These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit]. Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Ghosh S; Champlin RE; Ueno NT; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E Bone Marrow Transplant; 2001 Aug; 28(3):271-5. PubMed ID: 11535995 [TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429 [TBL] [Abstract][Full Text] [Related]
8. Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline. McCoy D; Wong E; Kuyumjian AG; Wynd MA; Sebti R; Munk GB Transpl Infect Dis; 2011 Apr; 13(2):117-21. PubMed ID: 20804534 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312 [TBL] [Abstract][Full Text] [Related]
10. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Aslan T; Fassas AB; Desikan R; Siegel D; Munshi N; Mehta J; Singhal S; Barlogie B; Anaissie E Bone Marrow Transplant; 1999 Sep; 24(5):505-9. PubMed ID: 10482934 [TBL] [Abstract][Full Text] [Related]
11. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867 [TBL] [Abstract][Full Text] [Related]
12. Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients. Molinos-Quintana A; Pérez-de Soto C; Gómez-Rosa M; Pérez-Simón JA; Pérez-Hurtado JM Bone Marrow Transplant; 2013 Feb; 48(2):265-8. PubMed ID: 23000643 [TBL] [Abstract][Full Text] [Related]
13. Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience. Tsitsikas DA; Oakervee H; Cavenagh JD; Gribben J; Agrawal SG; Mattes FM Br J Haematol; 2009 Sep; 146(5):574-6. PubMed ID: 19538531 [No Abstract] [Full Text] [Related]
14. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study. Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152 [TBL] [Abstract][Full Text] [Related]
15. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons. Falsey AR; Koval C; DeVincenzo JP; Walsh EE Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734 [TBL] [Abstract][Full Text] [Related]
16. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443 [TBL] [Abstract][Full Text] [Related]
17. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Marcelin JR; Wilson JW; Razonable RR; Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016 [TBL] [Abstract][Full Text] [Related]
18. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients. Hynicka LM; Ensor CR Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247 [TBL] [Abstract][Full Text] [Related]
19. [Severe respiratory syncytial virus pneumonia in a hematopoietic stem cells transplant recipient]. Pintado V; Quereda C; Pérez De Oteyza J; López Jiménez J Med Clin (Barc); 2001 Nov; 117(14):555-6. PubMed ID: 11707224 [No Abstract] [Full Text] [Related]
20. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]